Indo-Bangla Pharma suffers 91.65pc drop in profit

Business Desk :
Indo-Bangla Pharmaceuticals Limited suffered a 91.65 per cent dip in profit to Tk 11.62 lakh in the third quarter of the current financial year.
It made a profit of Tk 1.39 crore in the same quarter of 2021-22.
The EPS was Tk 0.01 in January-March of 2022-23 against Tk 0.12 in the same quarter of 2021-22, according to the unaudited financial statements.